The inverse correlation between the signatures KRAS targets and MYC targets that are observed in the RNA samples of the Ivy Gap study by ssGSEA (Fig. 5c) was also confirmed by CT-specific inference in the RNA data from bulk samples of the TCGA-GBM (Fig. 5d) and the CPTAC-GBM studies (Fig. 5e, Supplementary Fig. 36). Here, KRAS is linked to glioblastoma.